ALACT — Acticor Biotech SA Balance Sheet
0.000.00%
- €3.30m
- €5.73m
Annual balance sheet for Acticor Biotech SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 12.9 | 7.59 | 11.3 | 6.6 | 3.88 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.38 | 1.93 | 4.28 | 4.84 | 4.38 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 14.5 | 10.1 | 16.9 | 11.7 | 9.26 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.228 | 0.181 | 0.098 | 0.014 | 0.022 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 15.4 | 11 | 17.9 | 12.9 | 9.72 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.16 | 6.38 | 4.06 | 6.7 | 9.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.37 | 9.3 | 6.86 | 15.2 | 15 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9.03 | 1.72 | 11 | -2.24 | -5.31 |
| Total Liabilities & Shareholders' Equity | 15.4 | 11 | 17.9 | 12.9 | 9.72 |
| Total Common Shares Outstanding |